The cost of emulated target trials: Is real‐world data cheaper than randomized studies?

The authors declare no conflicts of interest. Dr. Barosa reports receiving grants from the Luso-American Development Foundation (FLAD) during the conduct of the study. Dr. Prasad reports receiving grants from Arnold Ventures Research funding during the conduct of the study; royalties from Johns Hopkins Press, Medscape and MedPage; consulting fees from UnitedHealthcare and OptumRx; subscription revenue from YouTube, Patreon and Substack outside the submitted work. No other disclosures were reported. The data that support the findings of this study are available from the corresponding author upon reasonable request. Data S1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Authors

Institutions

Publication Details

Journal
European Journal of Clinical Investigation
Published
2025-03-25
DOI
https://doi.org/10.1111/eci.70035
Citations
3
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
9.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The cost of emulated target trials: Is real‐world data cheaper than randomized studies?

Vinay Prasad, Mariana Barosa
3 citations
European Journal of Clinical Investigation
Health Systems, Economic Evaluations, Quality of Life
9.39
article

The cost of emulated target trials: Is real‐world data cheaper than randomized studies?

Vinay Prasad, Mariana Barosa
article en
3 citations

Abstract

The authors declare no conflicts of interest. Dr. Barosa reports receiving grants from the Luso-American Development Foundation (FLAD) during the conduct of the study. Dr. Prasad reports receiving grants from Arnold Ventures Research funding during the conduct of the study; royalties from Johns Hopkins Press, Medscape and MedPage; consulting fees from UnitedHealthcare and OptumRx; subscription revenue from YouTube, Patreon and Substack outside the submitted work. No other disclosures were reported. The data that support the findings of this study are available from the corresponding author upon reasonable request. Data S1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

European Journal of Clinical InvestigationVol. 55(7)
University of Lisbon (PT), University of California, San Francisco (US), Universidade Nova de Lisboa (PT)
Arnold Ventures, Fundação Luso-Americana para o Desenvolvimento
Openalex Percentile: Top 3%
Health Systems, Economic Evaluations, Quality of Life
9.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.